Obstetrics, gynecology and reproductive medicine guidelines

Tuberculosis

PubMed Free Full Text

Tuberculosis: drug resistance

Australia

• Department of Health and Ageing
  • National Tuberculosis Advisory Committee multi-drug resistant tuberculosis - Information Paper (October 2007) [2007]

Canada

• Public Health Agency of Canada
  • Tuberculosis: Drug resistance in Canada-2007 [2008]
  • Tuberculosis Drug Resistance: Summary Report for 2003 [2004]

Europe

• TBNET
  • Epidemiology and clinical management of XDR-TB: a systematic review by TBNET [2009]

International

• Cochrane Library
  • Drugs for preventing tuberculosis in people at risk of multiple-drug-resistant pulmonary tuberculosis

• International Council of Nurses
  • TB Guidelines for Nurses in the Care and Control of Tuberculosis and Multi-drug Resistant Tuberculosis [2008]

• Program for Appropriate Technology in Health (PATH)
  • MDR/XDR-TB Assessment and Monitoring Tool [2009]

South Africa

• South African Medical Research Council
  • Managing multidrug-resistant tuberculosis. Legal implications [2006]

United States of America

• CDC Tuberculosis (TB)
  • Drug-Resistant TB

• National Guideline Clearinghouse
  • Guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update. World Health Organization [2011]

WHO

• WHO Regional Office for Europe
  • Roadmap to prevent and combat drug-resistant tuberculosis : the consolidated action plan to prevent and combat multidrug- and extensively drug-resistant tuberculosis in the WHO European Region 2011-2015 [2011]
  • Expert consultation on antimicrobial resistance: report on a meeting 25 August 2010 [2011]
  • Eighth meeting of national tuberculosis programme managers and thirteenth Wolfheze workshop : Wolfheze 2008 : tuberculosis management, surveillance and evaluation in Europe with high rates or threat of multidrug resistant tuberculosis [2008]
  • European recommendations on surveillance of antituberculosis drug resistance [2000]

• World Health Organization
  • Towards universal access to diagnosis and treatment of multidrug-resistant and extensively drug-resistant tuberculosis by 2015 : WHO progress report 2011 [2011]
  • Rapid implementation of the Xpert MTB/RIF diagnostic test: technical and operational 'How-to'; practical considerations [2011]
  • Policy statement: automated real-time nucleic acid amplification technology for rapid and simultaneous detection of tuberculosis and rifampicin resistance: Xpert MTB/RIF system [2011]
  • Noncommercial culture and drug-susceptibility testing methods for screening patients at risk for multidrug-resistant tuberculosis: policy statement [2011]
  • Guidelines for the programmatic management of drug-resistant tuberculosis - 2011 update [2011]
  • Checklist of prerequisites to country implementation of Xpert MTB/RIF and key action points at country level [2011]
  • Multidrug-resistant tuberculosis (MDR-TB) indicators: a minimum set of indicators for the programmatic management of MDR-TB in national tuberculosis control programmes [2010]
  • Multidrug and extensively drug-resistant TB (M/XDR-TB) : 2010 global report on surveillance and response [2010]
  • Green light committee initiative of the working group on multidrug-resistant tuberculosis of the Stop TB partnership: annual report 2009 [2010]
  • Management of MDR-TB: A field guide [2009]
  • Guidelines for surveillance of drug resistance in tuberculosis [2009]
  • Green light committee initiative of the working group on MDR-TB of the Stop TB partnership: annual report 2008 [2009]
  • Global tuberculosis control and patient care : meeting report : a ministerial meeting of high M/XDR-TB burden countries [2009]
  • Guidelines for the programmatic management of drug-resistant tuberculosis [2008]
  • Green light committee initiative of the working group on MDR-TB of the Stop TB partnership: annual report 2007 [2008]
  • Anti-tuberculosis drug resistance in the world : fourth global report [2008]
  • The global MDR-TB & XDR-TB response plan 2007-2008 [2007]

Articles in journals

• Annual Reviews
  • Extensively Drug-Resistant Tuberculosis: A New Face to an Old Pathogen [2009]

• Antimicrobial Agents and Chemotherapy
  • A Balancing Act: Efflux/Influx in Mycobacterial Drug Resistance [2009]
  • Treatment of Chronic Infections with Rifamycins: Is Resistance Likely To Follow? [2003]
  • Evolution of Drug Resistance in Mycobacterium tuberculosis: Clinical and Molecular Perspective [2002]

• BioScience Trends
  • Multi-drug resistant tuberculosis: an iatrogenic problem [2010]

• BMC Infectious Diseases
  • Direct susceptibility testing for multi drug resistant tuberculosis: A meta-analysis [2009]
  • A commercial line probe assay for the rapid detection of rifampicin resistance in Mycobacterium tuberculosis: a systematic review and meta-analysis [2005]

• Bulletin of the World Health Organization
  • Surveillance of anti-tuberculosis drug resistance in the world: an updated analysis, 2007–2010 [2012]

• Clinical Infectious Diseases
  • Treatment Outcomes among Patients with Extensively Drug-Resistant Tuberculosis: Systematic Review and Meta-Analysis [2010]
  • Extensively Drug-Resistant Tuberculosis: “There must be some kind of way out of here” [2010]

• Deutsches Ärzteblatt International
  • Drug-resistant tuberculosis: a worldwide epidemic poses a new challenge [2010]

• European Respiratory Journal
  • Management of multidrug-resistant tuberculosis and patients in retreatment [2005]
  • Drug resistance in tuberculosis [2005]

• Expert Reviews
  • Managing drug-resistant tuberculosis: experiences from India [2010]

• Indian Journal of Medical Research
  • Multidrug-resistant tuberculosis [2004]
  • Drug resistance in tuberculosis in India [2004]

• Journal of Antimicrobial Chemotherapy
  • Activity of phenothiazines against antibiotic-resistant Mycobacterium tuberculosis: a review supporting further studies that may elucidate the potential use of thioridazine as anti-tuberculosis therapy [2001]

• Journal of Biosciences
  • Multidrug-resistant to extensively drug resistant tuberculosis: what is next? [2008]

• Journal of Infection in Developing Countries
  • Drug resistant Mycobacterium tuberculosis in Mexico [2009]

• PLoS Medicine
  • Randomized Trials to Optimize Treatment of Multidrug-Resistant Tuberculosis [2007]
  • Cost-Effectiveness of Treating Multidrug-Resistant Tuberculosis [2006]

• PLoS ONE
  • Treatment Outcomes of Multidrug-Resistant Tuberculosis: A Systematic Review and Meta-Analysis [2009]

• Proceedings of the National Academy of Sciences of the United States of America
  • Criteria for the control of drug-resistant tuberculosis [2000]

• Respiratory Research
  • The molecular basis of resistance to isoniazid, rifampin, and pyrazinamide in Mycobacterium tuberculosis [2001]

{Related topics}

• Guidelines
  • Tuberculosis: treatment